Concepedia
Statistics
Publications
5
Citations
145
H-Index
Active since
2013
Affiliations
Molecular Partners (Switzerland)(Current)
Utrecht University
University of Lausanne
Thermo Fisher Scientific (Netherlands)
Spiez Laboratory
Chloé Iss is an author at Molecular Partners (Switzerland) specializing in life sciences, molecular virology, and infectious diseases.
Publications per year
2013–2024
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 60 citations · Full text
Life Sciences, Infectious Diseases, Pharmacology +15
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
Marcel Walser, Sylvia Rothenberger, Daniel L. Hurdiss et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 35 citations · Full text
Life Sciences, Infectious Diseases, Pharmacology +16
Engineering a Human-Like Glycosylation to Produce Therapeutic Glycoproteins Based on 6-Linked Sialylation in CHO Cells
Nassimal El Maï, Sandrine Donadio-Andréi, Chloé Iss et al. · Methods in molecular biology · 2013 · 19 citations
Life Sciences, Biochemistry, Molecular Biology +17
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 18 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
Matteo Bianchi, Christian Reichen, Amelie Croset et al. · Cancer Immunology Research · 2024 · 13 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 5